Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Alle

FDA recall notice · announced December 13, 2023 · Padagis Us

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010. NDC: 0574-0118-30

Reason for recall

Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules

Notes

Distribution: Nationwide in the USA
Lot/code information: Lot: 231104, 231105, 231106, exp 7/31/2025
Quantity: 7,032 bottles
Status: Ongoing
Products in this recall event:
- Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-2 (D-0139-2024)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.